Volume | 10,214 |
|
|||||
News | - | ||||||
Day High | 8.24 | Low High |
|||||
Day Low | 8.01 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Profound Medical Corporation | PROF | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
8.13 | 8.01 | 8.24 | 8.03 | 8.03 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
117 | 10,214 | US$ 8.13 | US$ 83,072 | - | 7.11 - 15.49 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 5 | US$ 8.11 | USD |
Profound Medical Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
231.6M | 21.37M | - | 7.2M | -28.57M | -1.34 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Profound Medical News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PROF Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 7.79 | 8.39 | 7.30 | 7.86 | 21,508 | 0.24 | 3.08% |
1 Month | 8.34 | 8.68 | 7.30 | 8.03 | 22,932 | -0.31 | -3.72% |
3 Months | 8.78 | 9.4168 | 7.30 | 8.38 | 35,633 | -0.75 | -8.54% |
6 Months | 8.89 | 11.69 | 7.11 | 8.47 | 42,708 | -0.86 | -9.67% |
1 Year | 11.17 | 15.49 | 7.11 | 9.68 | 32,554 | -3.14 | -28.11% |
3 Years | 19.19 | 20.72 | 3.10 | 10.42 | 48,523 | -11.16 | -58.16% |
5 Years | 9.98 | 28.97 | 3.10 | 13.32 | 56,141 | -1.95 | -19.54% |
Profound Medical Description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner. |